ID: MRFR/Pharma/2913-HCR | February 2021 | Region: Global | 206 pages
Antihistamine drugs Market Overview
Antihistamines are drugs mainly used for treating allergies. They are also used to treat motion sickness, insomnia and anxiety. They work by acting against a chemical called histamine which leads to many allergic symptoms. Antihistamines may cause side effects such as dizziness, dry mouth, nervousness, irritability, blurry vision and decreased appetite.
The antihistamine drugs market is expected to grow at a CAGR of 9.8% during the forecast period and antihistamine drugs market is estimated to reach USD 280 million by 2023.
FIGURE 1 Global Antihistamine drugs Market by Region, 2016 (%)
Key Players in the Antihistamine drugs Market
Some of the key players in antihistamine drugs market are Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)
The antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.
On the basis of route of administration, the antihistamine drugs market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.
On the basis of indication, the antihistamine drugs market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the antihistamine drugs market is segmented into hospitals, clinics, pharmaceutical companies and others.
FIGURE 2 Research Methodology
Regional Analysis of the Antihistamine drugs Market
The American region accounts for the largest share of the global market due to rising prevalence of allergy rhinitis and rising demand for diagnosis and treatment of allergic disease. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies found in the U.S.
Europe is the second largest market that holds a noticeable share of the antihistamine drugs market. According to the European Academy of Allergy and Clinical Immunology (EAACI), more than 50% of all Europeans will suffer from allergy in coming years.
In Asia Pacific, increase in the demand for drugs for the treatment of allergies and skin diseases drive the antihistamine drugs market growth. There has been a rise in the number of dermatology clinics across Asia Pacific from past few years. High rates of allergic rhinitis and increasing awareness regarding treatments available for allergy is poised to drive the growth of antihistamine drugs market in Asia Pacific.
The Middle East & Africa, the antihistamine drugs market shows steady but positive growth due to the rising prevalence of nasal allergies.
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Route of Administration, Indication, End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The Antihistamine Drug Market valuation would be USD 280 million.
The CAGR would be 9.8% during the forecast period of 2018 to 2023.
The players are Sanofi (France), Johnson & Johnson Consumer Inc. (U.S.), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), Bayer AG (Germany), and Prestige Brands Holdings, Inc. (U.S.).
The types are sedating and non-sedating antihistamines.
The types are allergy, urticaria, dermatitis, and others.
1 Report Prologue
2 Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
3 Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4 Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain
5.3 Investment Feasibility Analysis
5.4 Price Factor Analysis
6 Global Antihistamine drugs Market, by Type
6.2 Sedating Antihistamine Drugs
6.3 Non-Sedating Antihistamine Drugs
6.3.3 Loratadine ODT
7 Global Antihistamine Drugs Market, By Route of Administration
7.2 Oral Route
7.3 Parenteral Route
7.3.3 Intravenous Route
7.4 Rectal Route
8 Global Antihistamine Drugs Market, by Indication
9 Global Antihistamine Drugs Market by End User
9.4 Pharmaceutical Companies
10 Global Antihistamine Drugs Market by Region
10.2.1 North America
10.2.2 Latin America
10.3.1 Western Europe
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.4 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.6 Rest of Middle East & Africa
11 Company Landscape
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Johnson & Johnson Consumer Inc.
12.1.1 Company Overview
12.1.2 Product Overview
12.1.4 SWOT Analysis
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Bayer AG
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Merck Sharp & Dohme Corp.
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial Overview
12.5.4 Key Developments
12.6 Prestige Brands Holdings, Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 CVS Pharmacy
12.7.2 Product Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pharmaceutical Industry